Skip to content

Emelie Perland

  • PhD
  • Product development specialist
  • Double bond pharmaceutical
  • 4h-indexImpact measure calculated using publication and citation counts. Updated daily.
  • 48CitationsNumber of citations received by Emelie's publications. Updated daily.

Research interests

Atypical SLCsSLCmembrane transportpharmacologymolecular biologycell biologyNeuroscience

Co-authors (47)

Publications (5)

  • A DNA methylation site within the KLF13 gene is associated with orexigenic processes based on neural responses and ghrelin levels

    • Wiemerslage L
    • Islam R
    • van der Kamp C
    • et al.
    N/AReaders
    N/ACitations
    Get full text
  • Characteristics of 29 novel atypical solute carriers of major facilitator superfamily type: evolutionary conservation, predicted structure and neuronal co-expression

    • Perland E
    • Bagchi S
    • Klaesson A
    • et al.
    N/AReaders
    N/ACitations
    Get full text
  • Putative Membrane-Bound Transporters MFSD14A and MFSD14B Are Neuronal and Affected by Nutrient Availability

    • Lekholm E
    • Perland E
    • Eriksson M
    • et al.
    N/AReaders
    N/ACitations
    Get full text
  • Structural prediction of two novel human atypical SLC transporters, MFSD4A and MFSD9, and their neuroanatomical distribution in mice

    • Perland E
    • Hellsten S
    • Schweizer N
    • et al.
    N/AReaders
    N/ACitations
    Get full text
  • The gene expression of the neuronal protein, SLC38A9, changes in mouse brain after in vivo starvation and high-fat diet

    • Hellsten S
    • Eriksson M
    • Lekholm E
    • et al.
    N/AReaders
    N/ACitations
    Get full text

Professional experience

Product development specialist

Double bond pharmaceutical

October 2017 - Present

PhD student at the Neuroscience department

Uppsala Universitet

November 2012 - September 2017(5 years)